Antifungal Drug Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2019 – 2028

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Antifungal Drugs Market Year-on-Year Growth, 2021 – 2030 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook, and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Antifungal Drugs Market by Drug Type: Market Size and Forecast, 2020 – 2030

4.1  Overview

4.2  Echinocandins

4.2.1   Current Trend and Analysis

4.2.2   Market Size and Forecast, 2020 – 2030 ($ Billion)

4.2.3   Market Size and Forecast by Region, 2020 – 2030 ($ Billion)

4.2.4   Caspofungin

4.2.5   Micafungin

4.2.6   Anidulafungin

4.2.7   Others

4.3  Azoles

4.3.1   Current Trend and Analysis

4.3.2   Market Size and Forecast, 2020 – 2030 ($ Billion)

4.3.3   Market Size and Forecast by Region, 2020 – 2030 ($ Billion)

4.3.4   Imidazoles

4.3.5   Voricanazole

4.3.6   Thiazole

4.3.7   Others

4.4  Polyenes

4.4.1   Current Trend and Analysis

4.4.2   Market Size and Forecast, 2020 – 2030 ($ Billion)

4.4.3   Market Size and Forecast by Region, 2020 – 2030 ($ Billion)

4.4.4   Amphotericin B

4.4.5   Candicidin

4.4.6   Hamycin

4.4.7   Natamycin

4.4.8   Others

4.5  Allylamines

4.5.1   Current Trend and Analysis

4.5.2   Market Size and Forecast, 2020 – 2030 ($ Billion)

4.5.3   Market Size and Forecast by Region, 2020 – 2030 ($ Billion)

4.5.4   Butenafine

4.5.5   Terbinafine

4.5.6   Naftifine

4.5.7   Others

Chapter 5        Global Antifungal Drugs Market by Infection Type: Market Size and Forecast, 2020 – 2030 

5.1  Overview

5.2  Superficial Antifungal Infections

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2020 – 2030 ($ Billion)

5.2.3   Market Size and Forecast by Region, 2020 – 2030 ($ Billion)

5.3  Systemic Antifungal Infections

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2020 – 2030 ($ Billion)

5.3.3   Market Size and Forecast by Region, 2020 – 2030 ($ Billion)

Chapter 6    Global Antifungal Drugs Market by Therapeutic Indications: Market Size and Forecast, 2020 – 2030

6.1  Overview

6.2  Aspergillosis

6.2.1   Current Trend and Analysis

6.2.2   Market Size and Forecast, 2020 – 2030 ($ Billion)

6.2.3   Market Size and Forecast by Region, 2020 – 2030 ($ Billion)

6.3  Dermatophytosis

6.3.1   Current Trend and Analysis

6.3.2   Market Size and Forecast, 2020 – 2030 ($ Billion)

6.3.3   Market Size and Forecast by Region, 2020 – 2030 ($ Billion)

6.4  Candidiasis

6.4.1   Current Trend and Analysis

6.4.2   Market Size and Forecast, 2020 – 2030 ($ Billion)

6.4.3   Market Size and Forecast by Region, 2020 – 2030 ($ Billion)

6.5  Others

6.5.1   Current Trend and Analysis

6.5.2   Market Size and Forecast, 2020 – 2030 ($ Billion)

6.5.3   Market Size and Forecast by Region, 2020 – 2030 ($ Billion)

Chapter 7    Global Antifungal Drugs Market by Dosage Forms: Market Size and Forecast, 2020 – 2030

7.1  Overview

7.2  Powders

7.2.1   Current Trend and Analysis

7.2.2   Market Size and Forecast, 2020 – 2030 ($ Billion)

7.2.3   Market Size and Forecast by Region, 2020 – 2030 ($ Billion)

7.3  Ointments

7.3.1   Current Trend and Analysis

7.3.2   Market Size and Forecast, 2020 – 2030 ($ Billion)

7.3.3   Market Size and Forecast by Region, 2020 – 2030 ($ Billion)

7.4  Drugs

7.4.1   Current Trend and Analysis

7.4.2   Market Size and Forecast, 2020 – 2030 ($ Billion)

7.4.3   Market Size and Forecast by Region, 2020 – 2030 ($ Billion)

7.5  Others

7.5.1   Current Trend and Analysis

7.5.2   Market Size and Forecast, 2020 – 2030 ($ Billion)

7.5.3   Market Size and Forecast by Region, 2020 – 2030 ($ Billion)

Chapter 8        Global Antifungal Drugs Market by Geography: Market Size and Forecast, 2020 – 2030   

8.1  Overview

8.1.1   Global Antifungal Drugs Market Year-on-Year Growth, by region 2021 – 2030 (%)

8.2  North America

8.2.1   Current Trend and Analysis

8.2.2   Market Size and Forecast, 2020 – 2030 ($ Billion)

8.2.3   U.S.

8.2.3.1        Market Size and Forecast, 2020 – 2030 ($ Billion)

8.2.3.2        By Drug Type

8.2.3.3        By Infection Type

8.2.3.4        By Therapeutic Infections

8.2.3.5        By Dosage Forms

8.2.4   Canada

8.2.4.1        Market Size and Forecast, 2020 – 2030 ($ Billion)

8.2.4.2        By Drug Type

8.2.4.3        By Infection Type

8.2.4.4        By Therapeutic Infections

8.2.4.5        By Dosage Forms

8.2.5   Mexico

8.2.5.1        Market Size and Forecast, 2020 – 2030 ($ Billion)

8.2.5.2        By Drug Type

8.2.5.3        By Infection Type

8.2.5.4        By Therapeutic Infections

8.2.5.5        By Dosage Forms

8.3    Europe

8.3.1   Current Trend and Analysis

8.3.2   Market Size and Forecast, 2020 – 2030 ($ Billion)

8.3.3   UK

8.3.3.1        Market Size and Forecast, 2020 – 2030 ($ Billion)

8.3.3.2        By Drug Type

8.3.3.3        By Infection Type

8.3.3.4        By Therapeutic Infections

8.3.3.5        By Dosage Forms

8.3.4   Russia

8.3.4.1        Market Size and Forecast, 2020 – 2030 ($ Billion)

8.3.4.2        By Drug Type

8.3.4.3        By Infection Type

8.3.4.4        By Therapeutic Infections

8.3.4.5        By Dosage Forms

8.3.5   France

8.3.5.1        Market Size and Forecast, 2020 – 2030 ($ Billion)

8.3.5.2        By Drug Type

8.3.5.3        By Infection Type

8.3.5.4        By Therapeutic Infections

8.3.5.5        By Dosage Forms

8.3.6   Italy

8.3.6.1        Market Size and Forecast, 2020 – 2030 ($ Billion)

8.3.6.2        By Drug Type

8.3.6.3        By Infection Type

8.3.6.4        By Therapeutic Infections

8.3.6.5        By Dosage Forms

8.3.7   Germany

8.3.7.1        Market Size and Forecast, 2020 – 2030 ($ Billion)

8.3.7.2        By Drug Type

8.3.7.3        By Infection Type

8.3.7.4        By Therapeutic Infections

8.3.7.5        By Dosage Forms

8.3.8   Rest of Europe

8.3.8.1        Market Size and Forecast, 2020 – 2030 ($ Billion)

8.3.8.2        By Drug Type

8.3.8.3        By Infection Type

8.3.8.4        By Therapeutic Infections

8.3.8.5        By Dosage Forms

8.4    Asia-Pacific

8.4.1   Current Trend and Analysis

8.4.2   Market Size and Forecast, 2020 – 2030 ($ Billion)

8.4.3   China

8.4.3.1        Market Size and Forecast, 2020 – 2030 ($ Billion)

8.4.3.2        By Drug Type

8.4.3.3        By Infection Type

8.4.3.4        By Therapeutic Infections

8.4.3.5        By Dosage Forms

8.4.4   India

8.4.4.1        Market Size and Forecast, 2020 – 2030 ($ Billion)

8.4.4.2        By Drug Type

8.4.4.3        By Infection Type

8.4.4.4        By Therapeutic Infections

8.4.4.5        By Dosage Forms

8.4.5   Japan

8.4.5.1        Market Size and Forecast, 2020 – 2030 ($ Billion)

8.4.5.2        By Drug Type

8.4.5.3        By Infection Type

8.4.5.4        By Therapeutic Infections

8.4.5.5        By Dosage Forms

8.4.6   Rest of Asia-Pacific

8.4.6.1        By Drug Type

8.4.6.2        By Infection Type

8.4.6.3        By Therapeutic Infections

8.4.6.4        By Dosage Forms

8.5      RoW

8.5.1   Current Trend and Analysis

8.5.2   Market Size and Forecast, 2020 – 2030 ($ Billion)

8.5.3   South & Central America

8.5.3.1        Market Size and Forecast, 2020 – 2030 ($ Billion)

8.5.3.2        By Drug Type

8.5.3.3        By Infection Type

8.5.3.4        By Therapeutic Infections

8.5.3.5        By Dosage Forms

8.5.4   Middle East

8.5.4.1        Market Size and Forecast, 2020 – 2030 ($ Billion)

8.5.4.2        By Drug Type

8.5.4.3        By Infection Type

8.5.4.4        By Therapeutic Infections

8.5.4.5        By Dosage Forms

8.5.5   Africa

8.5.5.1        Market Size and Forecast, 2020 – 2030 ($ Billion)

8.5.5.2        By Drug Type

8.5.5.3        By Infection Type

8.5.5.4        By Therapeutic Infections

8.5.5.5        By Dosage Forms

Chapter 9        Company Profiles

9.1  Merck & Co., Inc.

9.1.1     Company Overview

9.1.2     Product Portfolio

9.1.3     Business Strategies

9.1.4     Financials

9.1.5     Recent Developments

9.2  Pfizer Inc.

9.2.1     Company Overview

9.2.2     Product Portfolio

9.2.3     Business Strategies

9.2.4     Financials

9.2.5     Recent Developments

9.3  Gilead Sciences, Inc.

9.3.1     Company Overview

9.3.2     Product Portfolio

9.3.3     Business Strategies

9.3.4     Financials

9.3.5     Recent Developments

9.4  Sanofi S.A.

9.4.1     Company Overview

9.4.2     Product Portfolio

9.4.3     Business Strategies

9.4.4     Financials

9.4.5     Recent Developments

9.5  Novartis International AG

9.5.1     Company Overview

9.5.2     Product Portfolio

9.5.3     Business Strategies

9.5.4     Financials

9.5.5     Recent Developments

9.6  Abbott Laboratories

9.6.1     Company Overview

9.6.2     Product Portfolio

9.6.3     <span style="font-family: Arial, sans-serif; color: black;